- Aerosol orgotein (Ontosein) for the prevention of radiotherapy-induce…
Number of the records: 1  

Aerosol orgotein (Ontosein) for the prevention of radiotherapy-induced adverse effects in head and neck cancer patients: a feasibility study

  1. ESCRIBANO, A. et al. Aerosol orgotein (Ontosein) for the prevention of radiotherapy-induced adverse effects in head and neck cancer patients: a feasibility study. In Neoplasma. ISSN 0028-2685, 2002, roč. 49, č. 3, s. 201-208.
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.